1.88

3.30% 0.06

After Hours: 1.88

Caribou Biosciences Inc (CRBU)

Overview News Price History Option Chain Financials Why CRBU Down? Discussions Forecast

Caribou Biosciences Inc stock is traded at $1.88, with a volume of 641.50K. It is up +3.30% in the last 24 hours and down -3.59% over the past month. Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Previous Close:

$1.82

Open:

$1.85

24h Volume:

641.50K

Relative Volume:

0.54

Market Cap:

$181.68M

Revenue:

$11.16M

Net Income/Loss:

$-148.13M

P/E Ratio:

-1.1835

EPS:

-1.5885

Net Cash Flow:

$-112.35M

1W Performance:

-1.57%

1M Performance:

-3.59%

6M Performance:

-2.59%

1Y Performance:

+95.75%

1-Day Range:

$1.85

$1.955

1-Week Range:

$1.76

$1.98

52-Week Range:

$0.66

$3.535

Caribou Biosciences Inc Stock (CRBU) Company Profile

Name

Caribou Biosciences Inc

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

510-982-6030

Address

2929 7TH STREET, SUITE 105, BERKELEY

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CRBU's Discussions on Twitter

Compare CRBU vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRBU Caribou Biosciences Inc	1.88	175.88M	11.16M	-148.13M	-112.35M	-1.5885
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-03-24	Downgrade	Evercore ISI	Outperform → In-line
Nov-08-23	Initiated	Cantor Fitzgerald	Neutral
Oct-31-23	Initiated	Evercore ISI	Outperform
Jul-11-23	Initiated	Truist	Buy
Feb-18-22	Initiated	RBC Capital Mkts	Outperform
Dec-01-21	Initiated	Oppenheimer	Outperform
Nov-30-21	Initiated	H.C. Wainwright	Buy
Nov-15-21	Upgrade	Citigroup	Neutral → Buy
Aug-17-21	Initiated	BofA Securities	Buy
Aug-17-21	Initiated	Citigroup	Neutral
Aug-17-21	Initiated	SVB Leerink	Outperform

View All

Caribou Biosciences Inc Stock (CRBU) Latest News

Mar 25, 2026

How does Caribou Biosciences Inc compare to its peersPortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn

Mar 25, 2026

Mar 23, 2026

Caribou Biosciences stock faces pressure amid biotech volatility and pipeline updates - AD HOC NEWS

Mar 23, 2026

Mar 22, 2026

Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results - MSN

Mar 22, 2026

Mar 21, 2026

Aug Movers: Can Caribou Biosciences Inc expand its profit margins2026 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn

Mar 21, 2026

Market Catalysts: Is Caribou Biosciences Inc benefiting from interest rate changesWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

CRBU Earnings History & Surprises | EPS & Revenue Results | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill

Mar 20, 2026

Mar 19, 2026

Trading Action: How does Caribou Biosciences Inc compare to its peersInsider Buying & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Mar 19, 2026

Mar 18, 2026

Signal Recap: Is Caribou Biosciences Inc stock good for income investors2026 Macro Moves & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value - Seeking Alpha

Mar 17, 2026

Mar 14, 2026

Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink Conference - MarketBeat

Mar 14, 2026

Mar 10, 2026

CRBU Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 10, 2026

Analysts Are Bullish on Top Healthcare Stocks: Caribou Biosciences (CRBU), Oncology Institute (TOI) - The Globe and Mail

Mar 10, 2026

Mar 08, 2026

Drug Pricing Reforms Threaten Caribou Biosciences’ Future Margins and Market Access - The Globe and Mail

Mar 08, 2026

Mar 07, 2026

Caribou Biosciences: Advancing Allogeneic Cell Therapy Pipeline and Pivotal Trial Plans Support High-Risk Buy Rating - TipRanks

Mar 07, 2026

Mar 06, 2026

Truist reiterates Buy on Caribou Biosciences stock, $7 target - Investing.com Australia

Mar 06, 2026

Truist reiterates Buy on Caribou Biosciences stock, $7 target By Investing.com - Investing.com UK

Mar 06, 2026

Mar 05, 2026